Overview

Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer.

Status:
Completed
Trial end date:
2020-07-02
Target enrollment:
Participant gender:
Summary
To compare the incidence of lymphocele in Endometrial cancer patients with thrombin gel matrix used and not used during pelvic lymph node dissection.
Phase:
N/A
Details
Lead Sponsor:
Kocaeli University
Treatments:
Thrombin